STAT Inhibitors in Cancer / edited by Alister C Ward
Contributor(s): Ward, Alister C., editor literario
| SpringerLink (Online service)
Material type:
E-bookSeries: (Cancer Drug Discovery and Development, 2196-9906).Publisher: Cham : Springer International Publishing Imprint Humana Press, 2016Description: 1 recurso en línea (VII, 195 páginas) : 11 ilustraciones en color.ISBN: 9783319429496.Subject: Cáncer -- Investigación
| Item type | Current library | Collection | Call number | Copy number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|---|---|
LIBRO-E NO PRÉSTAMO
|
Madrid Digital Acceso Electrónico (UEM) | Ciencias de la Salud | RC268.4 .S73 2016 EB (Browse shelf(Opens below)) | .i11615345 | Acceso electrónico | eBOOK .i11615345 |
Browsing Madrid Digital shelves, Shelving location: Acceso Electrónico (UEM) Close shelf browser (Hides shelf browser)
| RC268.4 .N83 2014 EB Nuclear Signaling Pathways and Targeting Transcription in Cancer | RC268.4 .P556 2016 EB PI3K-mTOR in Cancer and Cancer Therapy | RC268.4 .R374 2016 EB Rare Hereditary Cancers : Diagnosis and Management | RC268.4 .S73 2016 EB STAT Inhibitors in Cancer | RC268.4 T445 2016 EB The Long and Short Non-coding RNAs in Cancer Biology | RC268.4 .T73 2014 EB Translation and Its Regulation in Cancer Biology and Medicine | RC268.4 .T74 2013 EB Trends in Stem Cell Proliferation and Cancer Research |
STATs in Health and Disease -- STAT Proteins in Cancer -- Translating STAT Inhibitors from the Lab to the Clinic -- Historical Development of STAT3 Inhibitors and Early Results in Clinical Trials -- STAT3 Inhibitors in Cancer: A Comprehensive Update -- Targeting Upstream Janus Kinases -- Inhibitors of Upstream Inducers of STAT Activation.
This volume, which includes contributions from leading scientists and clinicians in the field, provides definitive, state-of-the-art information on STAT inhibitors in a biological and clinical context. It gives an overview of the biology of the STAT family of transcription factors and their role in cancer etiology. Additionally, it describes the raft of therapeutic approaches being used to inhibit STATs in the context of various cancers, covering the full spectrum of therapeutic approaches to inhibiting STATs, and presenting emerging data from clinical trials.
There are no comments on this title.